Peptide Inhibitor for Human Immunodeficiency Virus Type 1 (HIV-1) Protease from a Thermolysin Hydrolysate of Oyster Proteins
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A peptide that inhibits HIV-1 protease was isolated from a hydrolysate of oyster (Crassostrea gigas) proteins digested with thermolysin. The peptide was using membrane filtration, gel permeation chromatography, ion exchange chromatography, and reverse-phase high performance liquid chromatography. Amino acid sequence of the peptide was determined to be Val-Phe-Glu-Leu. Chemically synthesized Val-Phe-Glu-Leu showed an IC50 value of 106 μM.
Abstract
A peptide that inhibits HIV-1 protease was isolated from a hydrolysate of oyster (Crassostrea gigas) proteins digested with thermolysin. The peptide was using membrane filtration, gel permeation chromatography, ion exchange chromatography, and reverse-phase high performance liquid chromatography. Amino acid sequence of the peptide was determined to be Val-Phe-Glu-Leu. Chemically synthesized Val-Phe-Glu-Leu showed an IC50 value of 106 μM.
참고문헌 (18)
- Achour A, "Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals", Biomed Phar-macother, 51, pp.427~429 (1997)
- Chin KP, "Vibrio vulnificus infection after raw oyster ingestion in a patient with liver disease and acquired immune deficiency syndrome-related complex", Gastroentero-logy, 92, pp.796~799 (1987)
- Huddleston JA, "The sequence of the nucleoprotein gene of human influenza A virus, strain A", NT, 68, pp.Nucleic Acids Res, 1982[DOI]
- Hur JM, "Inhibition effects of ninety nine Korean plants on human immunodeficiency virus type 1 protease activity", Nutraceuticals Food, 7, pp.123~127 (2002)
- Ichimura T, "HIV-1 protease inhibition and anti-HIV effect of natural and synthetic water-soluble lignin-like substances", Biosci Biotechnol Biochem, 63, pp.2202~2204 (1999)
- Ichimura T, "Inhibition of HIV-1 protease by water-soluble lignin-like sub-stance from an edible mushroom Fuscoporiaobliqua", Biosci Biotechnol Biochem, 62, pp.575~577 (1998)
- Kageyama S, "In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimeric HIV protease inhibitors containing allophenylnorstatine", Antimicrob Agents Chemother, 37, pp.810~817 (1993)
- Kohl NE, "Active human immunodeficiency virus protease is required for viral infectivity", Proc Natl Acad Sci USA, 85, pp.4686~4690 (1988)
- Matayoshi ED, "Novel Fluorogenic substrates for assaying retroviral proteases by resonance energy transfer", Science, 247, pp.954~958 (1990)
- Palmenberg AC, "The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region", Nucleic Acids Res, 12, pp.2969~2985 (1984)
- Pearl LH, "A structural model for the retroviral proteases", Nature, 329, pp.351~354 (1987)
- Richards AD, "Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases", FEBS Lett, 247, pp.113~117 (1989)
- Roberts NA, "Rational design of peptide-based HIV proteinase inhibitors", Science, 248, pp.358~361 (1990)
- Ross EE, "Vibrio vulnificus and molluscan shellfish : The necessity of education for high-risk individuals", J Am Diet Assoc, 94, pp.312~314 (1994)
- Seelmeier S, "Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A", Proc Natl Acad Sci USA, 85, pp.6612~6616 (1988)
- Stella S, "Isolation of α-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors", J Antibiotics, 44, pp.1019~1022 (1991)
- Toh H, "Retroviral protease-like sequence in the yeast transposon Ty 1", Nature, 315, pp.691~691 (1985)
- Yoshikawa T, "Free radical-scavenging activity of Crassostera gigas extract (JCOE)", Biomed & Pharmacother, 51, pp.328~332 (1997)
